Osteoporosis Update 1997. Symposium proceedings. Osaka, Japan, 13-16 November 1997.
出版信息
Osteoporos Int. 1997;7 Suppl 3:1-222.
PMID:9565455
Abstract
摘要
相似文献
1
Osteoporosis Update 1997. Symposium proceedings. Osaka, Japan, 13-16 November 1997.《1997年骨质疏松症最新进展》。研讨会论文集。日本大阪，1997年11月13日至16日。
Osteoporos Int. 1997;7 Suppl 3:1-222.
2
3
The 2nd International Conference on Osteoporosis. Osaka and Nara, Japan. November 13-16, 1997. Abstracts.第二届骨质疏松症国际会议。日本大阪和奈良。1997年11月13日至16日。摘要
Osteoporos Int. 1997;7 Suppl 2:1-93.
4
Fibrinolysis. Proceedings of the Second Osaka Symposium. Osaka, Japan, August 27, 1989.纤维蛋白溶解。第二届大阪研讨会会议记录。日本大阪，1989年8月27日。
Thromb Res Suppl. 1990;10:1-131.
5
Proceedings of the 3rd International Symposium on Adrenomedullin and PAMP. Osaka, Japan, November 21, 2002.第三届肾上腺髓质素与PAMP国际研讨会会议记录。日本大阪，2002年11月21日。
Hypertens Res. 2003 Feb;26 Suppl:S1-246.
6
2nd Osaka International Symposium on Gastroenterology. Osaka, Japan, November 22-23, 1993. Abstracts.第二届大阪国际胃肠病学研讨会。日本大阪，1993年11月22日至23日。摘要
Dig Dis Sci. 1994 Apr;39(4):897-927.
7
Proceedings of the International Taurine Symposium '95. Osaka, Japan, June 1995.
Adv Exp Med Biol. 1996;403:3-658.
8
Proceedings of the International Conference on Osteoporosis. Kobe, Japan, November 5-7, 1991.骨质疏松症国际会议论文集。日本神户，1991年11月5日至7日。
Osteoporos Int. 1993;3 Suppl 1:1-271.
9
Glucocorticoid receptors: evolution, structure, function and abnormalities. Proceedings of a symposium. Osaka, Japan, July 14 & 15, 1988.
Cancer Res. 1989 Apr 15;49(8 Suppl):2201s-303s.
10
Proceedings of the 8th International Symposium on SHR and Related Studies. Osaka, Japan, 18-20 October 1994.第八届自发性高血压大鼠及相关研究国际研讨会会议记录。日本大阪，1994年10月18 - 20日。
Clin Exp Pharmacol Physiol Suppl. 1995 Dec;22(1):S1-379.
引用本文的文献
1
Fracture in asian women with breast cancer occurs at younger age.亚洲女性乳腺癌患者骨折的发病年龄较轻。
PLoS One. 2013 Sep 12;8(9):e75109. doi: 10.1371/journal.pone.0075109. eCollection 2013.
本文引用的文献
1
Osteoporosis in rheumatoid arthritis.类风湿关节炎中的骨质疏松症。
Osteoporos Int. 1997;7 Suppl 3:S217-22. doi: 10.1007/BF03194376.
2
Steroid-induced osteoporosis.
Osteoporos Int. 1997;7 Suppl 3:S213-6. doi: 10.1007/BF03194375.
3
Importance of sustained high glucose condition in the development of diabetic osteopenia: possible involvement of the polyol pathway.
Osteoporos Int. 1997;7 Suppl 3:S209-12. doi: 10.1007/BF03194374.
4
Vitamin D and its analogs in chronic renal failure.维生素D及其类似物与慢性肾衰竭
Osteoporos Int. 1997;7 Suppl 3:S202-8. doi: 10.1007/BF03194373.
5
Clinical and pathogenic factors in dialysis-related amyloidosis: current research findings.透析相关淀粉样变性的临床和致病因素：当前研究发现
Osteoporos Int. 1997;7 Suppl 3:S197-201. doi: 10.1007/BF03194372.
6
Changes in bone mineral density at various sites in patients on hemodialysis due to chronic glomerulonephritis.慢性肾小球肾炎所致血液透析患者不同部位骨矿物质密度的变化
Osteoporos Int. 1997;7 Suppl 3:S193-6. doi: 10.1007/BF03194371.
7
Osteoporosis and atherosclerosis in chronic renal failure.慢性肾衰竭中的骨质疏松与动脉粥样硬化
Osteoporos Int. 1997;7 Suppl 3:S188-92. doi: 10.1007/BF03194370.
8
Pathogenesis and histology of renal osteodystrophy.
Osteoporos Int. 1997;7 Suppl 3:S184-7. doi: 10.1007/BF03194369.
9
Vitamin D and analogues in renal bone disease and implications for osteoporosis.
Osteoporos Int. 1997;7 Suppl 3:S179-83. doi: 10.1007/BF03194368.
10
Ipriflavone for the treatment of osteoporosis.依普黄酮治疗骨质疏松症。
Osteoporos Int. 1997;7 Suppl 3:S174-8. doi: 10.1007/BF03194367.
Zotero 插件